State Street Corp Processa Pharmaceuticals, Inc. Transaction History

State Street Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.68 - $3.55 $2,184 - $4,615	1,300 Added 3.13%	42,786 $120,000
Q3 2021 Nov 15, 2021	BUY	$5.28 - $8.61 $131,398 - $214,268	24,886 Added 149.92%	41,486 $356,000
Q2 2021 Aug 16, 2021	BUY	$6.15 - $10.95 $102,090 - $181,770	16,600 New	16,600 $136,000

Ticker PCSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,856,200
Market Cap $18.4M
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.